Story perspectives

Breakthrough Study Slows Alzheimer's Progression in Mice

3/23/2026

Summary

Story summary

Researchers at Heidelberg University, led by Prof. Dr. Hilmar Bading, identified a death complex formed by N-methyl-D-aspartate (NMDA) receptors and the transient receptor potential melastatin 4 (TRPM4) ion channel that drives Alzheimer's disease progression.
Using FP802, they disrupted this interaction in mice, slowing disease progression and preserving memory.
The strategy distinguishes itself from amyloid-targeting approaches.
The study was funded by various organizations.
The study was published in Molecular Psychiatry.

1 of 1

Story summary

Researchers at Heidelberg University, led by Prof. Dr. Hilmar Bading, identified a death complex formed by N-methyl-D-aspartate (NMDA) receptors and the transient receptor potential melastatin 4 (TRPM4) ion channel that drives Alzheimer's disease progression.
Using FP802, they disrupted this interaction in mice, slowing disease progression and preserving memory.
The strategy distinguishes itself from amyloid-targeting approaches.
The study was funded by various organizations.
The study was published in Molecular Psychiatry.